Dr. Nephi Stella founded Stella Therapeutics in March 2011. He is a Professor of Pharmacology, Psychiatry and Behavioral Sciences at the University of Washington in Seattle. Dr. Stella has over 25 years of experience studying cell-signaling mechanisms that are relevant to neuro-oncology, neuroinflammation, and neurodegeneration. His work has resulted in multiple patents and over 40 published manuscripts in journals including Nature and Science. As an internationally recognized expert in cell signaling, Dr. Stella has been invited to speak at numerous conferences around the world and has leveraged these opportunities to build a global network of contacts in both the pharmaceutical industry and academia. Groundbreaking research from the Stella laboratory represents the technological foundation of Stella Therapeutics.
Mr. Howse is currently a Director of Capstone Therapeutics (CAPS) and several private companies. He was a co-founder of Cable & Howse Ventures and Cable, Howse, & Ragen Investment Banking firm. He has served as a corporate director and advisor for various public, private, and non-profit ventures. Mr. Howse received a Bachelor’s and M.B.A. from Stanford and served in the U.S. Navy submarine force.
Mr. Mattioli has over 25 years’ experience in founding, managing and growing technology and biotech startup companies. Currently, President & CEO of Point of Data, he has held multiple senior management and corporate director positions for various public and private organizations including Founder & CEO of YottaYotta and CEO of SEEK Systems. Mr. Mattioli received his Bachelor’s degree and MEC from Arizona State University.